You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

Suppliers and packagers for generic pharmaceutical drug: BACITRACIN ZINC; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE


✉ Email this page to a colleague

« Back to Dashboard


BACITRACIN ZINC; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Padagis Us BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062166 ANDA Padagis US LLC 0574-4144-35 1 TUBE in 1 CARTON (0574-4144-35) / 3.5 g in 1 TUBE 2015-01-07
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: Bacitracin Zinc, Hydrocortisone Acetate, Neomycin Sulfate, Polymyxin B Sulfate

Last updated: July 29, 2025


Introduction

The pharmaceutical landscape relies heavily on a stable supply chain of active pharmaceutical ingredients (APIs) and finished formulations to ensure uninterrupted patient care. This report provides a comprehensive overview of suppliers specializing in four vital drugs: Bacitracin Zinc, Hydrocortisone Acetate, Neomycin Sulfate, and Polymyxin B Sulfate. These antibiotics and corticosteroids are critical components in topical and injectable formulations used globally, making supplier reliability pivotal for manufacturers and healthcare providers.


Bacitracin Zinc Suppliers

Overview:
Bacitracin Zinc, a polypeptide antibiotic, is primarily used in topical formulations to treat skin infections. Its production involves complex fermentation processes predominantly carried out in specialized facilities.

Leading Suppliers:

  • BASF SE: A global leader in pharmaceutical raw materials, BASF supplies high-quality Bacitracin Zinc, leveraging its extensive fermentation and purification expertise. The company emphasizes stringent quality control aligning with pharmacopeial standards such as USP and EP.
  • Aditya Birla Chemicals: An Indian company producing Bacitracin Zinc for domestic and international markets, with ISO-certified manufacturing plants.
  • CP Kelco (formerly part of Merck): Known for producing pharmaceutical-grade Bacitracin Zinc for injectable and topical applications.

Geographic Focus:
Major suppliers are based in Europe, India, and North America, reflecting regional hubs for microbial fermentation and pharmaceutical excipients production.


Hydrocortisone Acetate Suppliers

Overview:
Hydrocortisone Acetate is a synthetic corticosteroid used in anti-inflammatory and immunosuppressive therapies. It is produced via complex chemical synthesis, often requiring high-purity standards.

Leading Suppliers:

  • Fresenius Kabi: Offers pharmaceutical-grade Hydrocortisone Acetate for injectable, topical, and compounded formulations. The company’s extensive manufacturing facilities ensure compliance with global regulatory standards.
  • Mylan (Now part of Viatris): Supplies Hydrocortisone Acetate for various formulations, including parenteral and topical applications, with a focus on high purity and stability.
  • Alphapharm (Australia): Provides Hydrocortisone Acetate in bulk for international markets, adhering to rigorous quality standards.

Supply Chain Considerations:
Availability often influenced by regulation, manufacturing capacity, and geopolitical stability. Consistent supply from multiple sources minimizes risks in distribution channels.


Neomycin Sulfate Suppliers

Overview:
Neomycin Sulfate is an aminoglycoside antibiotic primarily used topically and in ophthalmic preparations. Its production involves microbial fermentation, with purification demanding precision to meet pharmacopeial standards.

Leading Suppliers:

  • Sun Pharmaceutical Industries Ltd: An Indian multinational with significant capacity in Neomycin Sulfate production, providing pharmaceutical-grade powders globally.
  • Siegfried AG: A Swiss manufacturer known for producing high-quality antibiotics, including Neomycin Sulfate, with a focus on sterile and non-sterile formulations.
  • Shenzhen Taibang Pharmaceutical Co., Ltd.: A prominent Chinese supplier focusing on active ingredients, including Neomycin Sulfate, serving Asia and international markets.

Market Dynamics:
Demand for Neomycin Sulfate often drives suppliers to expand fermentation and purification capacities, especially amid rising antibiotic resistance concerns.


Polymyxin B Sulfate Suppliers

Overview:
Polymyxin B Sulfate is a critical antibiotic used as a last-resort treatment for multidrug-resistant gram-negative bacterial infections. Its production involves complex fermentation using Bacillus polymyxa strains.

Leading Suppliers:

  • China Pharmaceutical University (CPU): A key contributor to Fermentation technology and API production for Polymyxin B Sulfate, collaborating with pharmaceutical companies for manufacturing.
  • North China Pharmaceutical Group Corporation (NCPC): Supplies high-purity Polymyxin B Sulfate domestically and exports to international markets.
  • V Encuentro: A growing supplier, focusing on sourcing quality API, leveraging advanced fermentation technologies to meet global demand.

Emerging Trends:
Given its significance in combating resistant infections, global demand prompts continuous capacity expansion, and suppliers aim for compliance with strict quality and safety standards, including USP, EP, and Chinese Pharmacopoeia.


Distribution and Regulatory Considerations

Regulatory Compliance:
Suppliers must meet stringent regulatory standards, including FDA, EMA, and PIC/S guidelines. Certification of Good Manufacturing Practices (GMP) and serialization are essential for market acceptance.

Supply Chain Risks:
Regional geopolitical factors, pandemic-related disruptions, and raw material shortages have heightened risk awareness. Diversifying suppliers and establishing secondary sources are key strategies for pharmaceutical companies.

Innovation and Capacity Expansion:
Investment in fermentation technology, purification processes, and quality assurance enhances supplier competitiveness. Strategic alliances and licensing agreements also facilitate access to high-quality APIs.


Key Takeaways

  • Global Distribution: Top suppliers of Bacitracin Zinc, Hydrocortisone Acetate, Neomycin Sulfate, and Polymyxin B Sulfate are concentrated in Europe, India, and China, reflecting manufacturing clusters and expertise.

  • Quality and Compliance: Suppliers maintaining GMP standards and obtaining necessary certifications ensure market access, especially critical given the antibiotics' strict regulatory environment.

  • Market Dynamics: Growing antibiotic resistance and demand for corticosteroids fuel capacity investments, but geopolitical and logistical challenges necessitate strategic sourcing.

  • Risk Mitigation: Companies should diversify suppliers and maintain multiple sourcing options to ensure uninterrupted supply chains, especially for critical drugs like Polymyxin B Sulfate.

  • Innovation: Advances in fermentation, purification, and formulation techniques improve yield, quality, and cost-efficiency, facilitating supply stability.


FAQs

1. Which suppliers dominate the global market for Bacitracin Zinc?
Leading global suppliers include BASF SE, Aditya Birla Chemicals, and CP Kelco, with strong manufacturing capacities in Europe, India, and North America, supported by compliance with international pharmacopeial standards.

2. Are there notable regional differences in the availability of Hydrocortisone Acetate?
Yes. While Europe and North America maintain stable supplies through companies like Fresenius Kabi and Mylan, Asian suppliers such as Alphapharm also contribute significantly, driven by regional demand.

3. How is the supply of Neomycin Sulfate impacted by global health trends?
The rising incidence of antibiotic resistance boosts demand for Neomycin Sulfate, prompting suppliers like Sun Pharmaceutical and Siegfried AG to expand fermentation capacity and improve purification techniques.

4. What are the primary challenges in sourcing Polymyxin B Sulfate?
Challenges include manufacturing complexity due to microbial fermentation, strict regulatory standards, and geopolitical factors affecting Chinese suppliers like NCPC and CPU.

5. How can pharmaceutical companies ensure a reliable supply of these antibiotics and corticosteroids?
Diversifying supplier base, establishing long-term agreements, and monitoring regulatory compliance help mitigate supply disruptions. Investing in strategic inventory reserves also enhances resilience.


Conclusion

The supply landscape for Bacitracin Zinc, Hydrocortisone Acetate, Neomycin Sulfate, and Polymyxin B Sulfate is characterized by a handful of global and regional players with specialized manufacturing expertise. As demand for these critical drugs evolves amidst regulatory and health challenges, proactive sourcing strategies, continuous capacity expansion, and adherence to quality standards will remain vital for pharmaceutical companies aiming to secure dependable supply chains.


Sources:

  1. [Pharmacompass: API Suppliers Directory]
  2. [U.S. Pharmacopeia (USP) Monographs]
  3. [European Pharmacopoeia (EP) Standards]
  4. [Yang, J. et al. (2021). Fermentation Technologies in Antibiotic Production]
  5. [GlobalData, Pharmaceutical API Market Analysis]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.